[Advance in studies on antitumor and immunomodulatory effects of wogonin]

Insights

Wogonin, a natural flavonoid, exhibits potent antitumor and immunomodulatory effects. It targets multiple pathways to induce cancer cell death and enhance the body's immune response against tumors.

Area of Science:

  • Natural product chemistry
  • Pharmacology
  • Immunology

Background:

  • Wogonin is a flavonoid with documented biological activities.
  • Emerging research highlights its potential in cancer therapy.

Purpose of the Study:

  • To review and summarize the antitumor and immunomodulatory effects of wogonin.
  • To consolidate current understanding of wogonin's multi-target mechanisms in cancer.

Main Methods:

  • Literature review of preclinical and clinical studies on wogonin.
  • Analysis of wogonin's molecular mechanisms against cancer.
  • Evaluation of wogonin's impact on immune system components.

Main Results:

  • Wogonin demonstrates multi-pathway, multi-target antitumor activities.
  • Mechanisms include inducing apoptosis (ROS/Ca2+-mediated), enhancing cytotoxicity (TNF-α, TRAIL), cell cycle arrest, inhibiting angiogenesis, and synergistic effects with chemotherapy.
  • Wogonin enhances immune function by promoting immune cell infiltration, regulating phenotypes, and cytokine secretion.

Conclusions:

  • Wogonin possesses significant antitumor potential through diverse molecular targets.
  • Its immunomodulatory properties further support its role in cancer treatment.
  • Further research into wogonin as a therapeutic agent is warranted.

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.9K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.8K
Tumor Progression02:07

Tumor Progression

3.7K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
8.0K